@techreport{10665-354214,
  author    = {Всемирная организация здравоохранения},
  title     = {{Предварительные рекомендации по применению инактивированной вакцины CoronaVac против COVID-19, разработанной Sinovac: Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.)}},
  year      = {2022},
  publisher = {Всемирная организация здравоохранения. Европейское региональное бюро},
  url       = {https://iris.who.int/handle/10665/354214},
}

@misc{10665-354214.sec-004.1,
  year = {2022},
  url  = {https://www.who.int/immunization/sage/Guidelines_development_recommendations.pdf},
}

@misc{10665-354214.sec-004.2,
  year = {2022},
  url  = {https://apps.who.int/iris/handle/10665/337569},
}

@misc{10665-354214.sec-004.3,
  year = {2022},
  url  = {https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2022.1},
}

@misc{10665-354214.sec-004.4,
  year = {2022},
  url  = {https://www.who.int/publications/i/item/who-sage-values-framework-for-the-allocation-and-prioritization-of-covid-19-vaccination},
}

@misc{10665-354214.sec-004.5,
  year = {2022},
  url  = {https://apps.who.int/iris/handle/10665/341455},
}

@article{10665-354214.sec-004.6,
  year = {2021},
  doi  = {10.1056/NEJMoa2107715},
}

@misc{10665-354214.sec-004.7,
  year = {2021},
  doi  = {10.1101/2021.08.03.21261544},
}

@misc{10665-354214.sec-004.8,
  year = {2021},
  doi  = {10.1101/2021.07.23.21261026},
}

@article{10665-354214.sec-004.9,
  year = {2022},
}

@misc{10665-354214.sec-004.10,
  doi = {10.2139/ssrn.4005130},
  url = {https://ssrn.com/abstract=4005130},
}

@misc{10665-354214.sec-004.11,
  year = {2021},
  url  = {https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE-recommendation-heterologous-schedules},
}

@misc{10665-354214.sec-004.12,
  year = {2021},
  doi  = {10.1101/2021.10.29.21265248},
  url  = {https://doi.org/10.1101/2021.10.29.21265248},
}

@misc{10665-354214.sec-004.13,
  year = {2021},
  url  = {https://www.who.int/publications/i/item/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply},
}

@article{10665-354214.sec-004.14,
  year = {2021},
  doi  = {10.1001/jamanetworkopen.2021.20456},
}

@article{10665-354214.sec-004.15,
  year = {2020},
  doi  = {10.1136/bmj.m3320},
}

@misc{10665-354214.sec-004.16,
  year = {2021},
  doi  = {10.1101/2021.12.14.21267777},
}

@misc{10665-354214.sec-004.17,
  year = {2022},
  url  = {https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-immunocompromised-persons},
}

@misc{10665-354214.sec-004.18,
  doi = {10.1126/sciimmunol.abn8014},
}

@misc{10665-354214.sec-004.19,
  year = {2022},
  url  = {https://apps.who.int/iris/handle/10665/334294},
}
